The New York Times

Trial of Controversial Alzheimer’s Drug Halted After Disappointing Results

[ad_1]

Cassava Sciences said that its drug did not significantly reduce cognitive decline in 1,900 people with mild to moderate Alzheimer’s disease.

[ad_2]

Source link : https://www.nytimes.com/2024/11/25/health/cassava-alzheimers-simuflam.html

Author : Teddy Rosenbluth

Publish date : 2024-11-26 01:42:26

Copyright for syndicated content belongs to the linked Source.

Tags : The New York Times